Cancer patients in India are facing a critical shortage of life-saving chemotherapy drugs, Cisplatin and Carboplatin, disrupting treatment schedules. Hospitals report dwindling stocks, forcing patients to scramble for supplies.

Doctors warn that prolonged unavailability of these essential medicines, with limited alternatives, could negatively impact patient outcomes and survival rates.